BRAF gene deletion broadens the clinical spectrum neuro-cardio-facial-cutaneous syndromes

J Child Neurol. 2011 Dec;26(12):1593-6. doi: 10.1177/0883073811413830. Epub 2011 Aug 23.

Abstract

Point mutations in the human BRAF gene are associated with a group of heterogeneous autosomal dominant neuro-cardio-facial-cutaneous syndromes. We identified a novel 93 kb intragenic deletion of the BRAF gene in a boy with severe developmental encephalopathy using microarray-based comparative genomic hybridization. The unique genotype and phenotype in this patient expands the spectrum of BRAF-related neurodevelopmental disorders. We propose a BRAF gene loss-of-function mechanism to best explain the biological basis of this severe developmental encephalopathy with postnatal growth deficiency.

Publication types

  • Case Reports

MeSH terms

  • Developmental Disabilities / complications
  • Developmental Disabilities / genetics
  • Electroencephalography
  • Facial Dermatoses / complications
  • Facial Dermatoses / genetics*
  • Heart Diseases / complications
  • Heart Diseases / genetics
  • Humans
  • Infant
  • Male
  • Microarray Analysis
  • Nervous System Diseases / complications
  • Nervous System Diseases / genetics
  • Proto-Oncogene Proteins B-raf / genetics*
  • Sequence Deletion / genetics*

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf